Growing stock of unused COVID vaccines a financial risk for vaccine manufacturers
Slump in Covid cases across the world has resulted in a drop in demand for COVID jabs. The situation has made it difficult for vaccine makers to make up their losses. Recently Novavax urged the US govt to come up with a purchase commitments for their COVID-19 vaccine to help the firm stay afloat
Driven by plummeting numbers of COVID cases across the world post-pandemic, several vaccine manufacturers are dealing with a slump in vaccine demand. The low level of COVID cases is also encouraging the government to pause coming up with another booster dose. The falling demand for vaccines across western nations like the US, UK, etc, is a major concern for vaccine makers who are sitting over a large inventory of unused COVID vaccines.